How it works
By thoroughly analyzing previous cases, enhanced by market trends and predictions, we apply our prioprietary 4x4 matrix to map:
→ technology scalability under physical & regulatory limitations (horizontal + vertical)
→ exit strategy + business model
→ early-stage asset monetization
→ funding opportunities (stacks of strategic + public + equity funds)
Why this approach
According to BCG, McKinsey and Hello Tomorrow, 92% of deep tech startups (and 70% of scienific innovation in general) fail.
Primary reasons are:
→ lack of structure and skills to translate breakthroughs into ventures
→ treating strategy as optional
→ forcing science into software playbooks
It's not because the science is bad. It's a systemic pattern. (Source: 1, 2, 3)
Why now
Time kills innovation. Most founders wait too long, or move too soon. Based on previous data (130+ supported projects and historical cases), and market analysis, it approximately takes:
→ 4-6 months to close an industry deal or monetize intangible assets
→ 6-9 months to close an investor deal
→ 9-12 months to get public funding and grant money.
Add 1-3 months of strategy development on top.
Trusted by leading
global venture programs
Serious about outcomes? So are we.
We engineer funding outcomes - for those already in the game.
If you’re
‣ in academia or pre-money but all-in,
‣ scaling horizontally or vertically, or
‣ investing and want fewer flops,
this is where the capital logic begins.
Interested in working with us?
We categorically reject the lean startup playbook. Science defies it by default.
Science-driven ventures aren’t just another kind of startup – they follow different laws. Literally. Physical constraints. Chemical boundaries. Regulatory frameworks.
None of that fits into MVPs, build-measure-learn loops, or imaginary TAM slides.
Those are just offensive to science.
At Arise, we start where the lean approach fails:
We work from the inside out – from molecular behavior to market architecture.
That’s the edge. That’s why it works.
We don't guess. We engineer fundability of what others called "non-fundable"
– and deliver results. Basta.
We're opinionated – very much so. See for yourself:
About
Maria Witte, CEO
Arise Innovations
- where Science meets Funding Strategy & Innovation becomes Reality
Our strength lies in developing tailor-made financing strategies for deep tech innovations that intelligently combine public funding, private investments and other resources.
With our expertise in acquiring financing and a strategic approach, we help companies discover hidden opportunities, successfully implement projects and secure long-term growth.
We accompany our clients through every phase – from ideation to scaling – and minimize risks while paving the way to sustainable success.
